AJR Am J Roentgenol

1. XU C, Zou L, He S, Zhang T, et al
   Comparison of Super-Resolution Deep-Learning Reconstruction and Hybrid Iterative Reconstruction for Coronary Stent Assessment on CTA: A Prospective Multicenter Study.
   AJR Am J Roentgenol. 2026 Jul 15. doi: 10.2214/AJR.26.34957.
   

   >> Share

   
   

   
   Am Heart J

2. BERTOLET M, Triulzi DJ, Campbell-Lee S, Gordeuk VR, et al
   Design, rationale, and baseline patient characteristics for the Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange (SCD-CARRE) trial.
   Am Heart J. 2026 Jul 15:107542. doi: 10.1016/j.ahj.2026.107542.
   

   >> Share

   
   
3. OPOLSKI MP, Spiewak M, Machaj F, Borzuta H, et al
   Antegrade dissection and re-entry versus retrograde strategy in chronic total occlusion percutaneous coronary intervention: Rationale and design of the ADRENALINE randomized study.
   Am Heart J. 2026 Jul 11:107538. doi: 10.1016/j.ahj.2026.107538.
   

   >> Share

   
   
4. GIANNAKOPOULOU SP, Chrysohoou C, Antonopoulou S, Barkas F, et al
   Integrative assessment of high-sensitivity C-reactive protein and lipid levels in predicting 20-year atherosclerotic cardiovascular disease risk, in a Mediterranean population: The ATTICA study (2002-2022).
   Am Heart J. 2026 Jul 11:107540. doi: 10.1016/j.ahj.2026.107540.
   

   >> Share

   
   
5. SCHEIER TC, Gerstein HC, Mosterd A, Qilong Y, et al
   Interpreting apparent differences among the major colchicine trials for cardiovascular prevention: a descriptive compatibility analysis.
   Am Heart J. 2026 Jul 11:107539. doi: 10.1016/j.ahj.2026.107539.
   

   >> Share

   
   

   
   Am J Cardiol

6. CHOI SH, Lee KJ, Jang JH, Baek YS, et al
   Prognostic implications of high platelet reactivity according to DAPT score after drug-eluting stent implantation: Insight from the PTRG-DES consortium.
   Am J Cardiol. 2026 Jul 16:S0002-9149(26)00452.
   

   >> Share

   
   
7. WANG J
   Clarifying analysis inconsistencies in a study of GLP-1RAs and cardiovascular outcomes in non-diabetic patients with atherosclerotic disease and obesity.
   Am J Cardiol. 2026 Jul 12:S0002-9149(26)00451.
   

   >> Share

   
   

   
   Angiology

8. YU C, Chen Z, Zhu Y
   Recent Advances in the Relationship Between Thyroid Hormone Sensitivity and Cardiovascular Diseases: A Narrative Review.
   Angiology. 2026 Jul 17:33197261467578. doi: 10.1177/00033197261467578.
   

   >> Share

   
   

   
   Atherosclerosis

9. LIAO CC, Hu WC, Yang SF, Li JM, et al
   Genome-wide cross-trait analysis reveals immunogenetic pleiotropy between autoimmune diseases and myocardial infarction and prioritizes therapeutic targets.
   Atherosclerosis. 2026;420:121849.
   

   >> Share

   
   

   
   Can J Cardiol

10. AYTEKIN A, Voll F, Simonetti F, Blum E, et al
    Clinical and Angiographic Outcomes Following Percutaneous Treatment of Chronic Totally Occluded Versus Non-Totally Occluded Coronary Vessels.
    Can J Cardiol. 2026;42:1490-1501.
    

    >> Share

    
    
11. RAZAVI AA, Sallam A, Lim B, Sharew B, et al
    Reevaluating Internal Thoracic Artery Use in Octogenarians Undergoing Multivessel Coronary Artery Bypass Grafting.
    Can J Cardiol. 2026;42:1665-1672.
    

    >> Share

    
    

    
    Cardiovasc Res

12. ZHAO J, Ruan Y, Chen Y, Chen Q, et al
    Urea cycle fumarate limits fibrosis post-myocardial infarction by reducing fibroblast mitochondrial adenosine triphosphate production.
    Cardiovasc Res. 2026;122:1359-1373.
    

    >> Share

    
    

    
    Circ Res

13. ZHOU R, Cai D, Chen SY
    Immune Targeting of Oligomeric Ninjurin 1 Protects Against Myocardial Infarction in Mice.
    Circ Res. 2026 Jul 15:10.1161/CIRCRESAHA.126.328766.
    

    >> Share

    
    
14. BAI Y, Zhao T, Wang Q, Zhang R, et al
    NUAK1 Inhibition Alleviates Ischemia-Reperfusion Injury via SYNE1-YAP1.
    Circ Res. 2026;139:e328256.
    

    >> Share

    
    

    
    Circulation

15. JOYNT MADDOX KE
    An Integrated Ecosystem for Cardiovascular Science and Health.
    Circulation. 2026;154:85-87.
    

    >> Share

    
    
16. GENTILE F, Emdin M, Clemente A
    Response by Gentile et al to Letters Regarding Article, "Clinical and Prognostic Significance of Anomalous Origin of a Coronary Artery in Adults".
    Circulation. 2026;154:e22-e23.
    

    >> Share

    
    
17. HAN QJ, Stefanescu Schmidt AC, DeFaria Yeh D
    Letter by Han et al Regarding Article, "Clinical and Prognostic Significance of Anomalous Origin of a Coronary Artery in Adults".
    Circulation. 2026;154:e18-e19.
    

    >> Share

    
    
18. LI Q, Zhang P
    Letter by Li and Zhang Regarding Article, "Clinical and Prognostic Significance of Anomalous Origin of a Coronary Artery in Adults".
    Circulation. 2026;154:e20-e21.
    

    >> Share

    
    

    
    Clin Cardiol

19. ARNOLD R, Gervasoni R, Ledermann B, Moulis L, et al
    Long-Term Follow-up After Percutaneous Coronary Interventions for Chronic Total Occlusions.
    Clin Cardiol. 2026;49:e70414.
    

    >> Share

    
    

    
    Eur Heart J

20. QI Y, Li J, Yang Z, Liu J, et al
    Cardiovascular disease in China: epidemiological evolution and implications.
    Eur Heart J. 2026 Mar 25:ehaf1121. doi: 10.1093/eurheartj/ehaf1121.
    

    >> Share

    
    
21. RAVEENDRA K, Gale CP
    Translating evidence of beta-blocker effectiveness following myocardial infarction.
    Eur Heart J. 2026 Jul 17:ehag506. doi: 10.1093.
    

    >> Share

    
    

    
    Heart

22. DRISCOLL TJ, Black S, Davies G, Gale CP, et al
    Prehospital 12-lead ECG and outcomes in acute coronary syndrome.
    Heart. 2026;112:847-854.
    

    >> Share

    
    

    
    J Am Coll Cardiol

23. SALAZAR JW, Nakasuka K, Connolly AJ, Moffatt E, et al
    Sudden Cardiac Death and its Relation to Previously Diagnosed or Occult Cardiac Disease at Autopsy.
    J Am Coll Cardiol. 2026;88:150-166.
    

    >> Share

    
    
24. LUO H, Chen R, Kan H
    Beyond PM(2.5) Mass: Constituent-Specific Cardiovascular Risks and Implications for Air Pollution Control.
    J Am Coll Cardiol. 2026 Jul 3:S0735-1097(26)06757.
    

    >> Share

    
    
25. GALLI M, Capodanno D, Berg JT, Cavallari LH, et al
    Aspirin Withdrawal in Patients With Coronary Artery Disease.
    J Am Coll Cardiol. 2026 Jul 8:S0735-1097(26)06769.
    

    >> Share

    
    
26. RIKHI R, Chen H, Mirzai S, Bhatia HS, et al
    The Role of Coronary Artery Calcium in Statin Eligibility Based on the American Heart Association's PREVENT Calculator: Insights From MESA.
    J Am Coll Cardiol. 2026 Jul 7:S0735-1097(26)06707.
    

    >> Share

    
    
27. WANG W, Liu H, Li Q, Dou Y, et al
    Long-Term Exposure to PM(2.5) Constituents and Coronary Heart Disease Risk in China.
    J Am Coll Cardiol. 2026 Jul 2:S0735-1097(26)06655.
    

    >> Share

    
    
28. DHARMAKUMAR R, Youssef K
    Cardiac MRI of Chronic Myocardial Infarction: Emergence of a New Era?
    J Am Coll Cardiol. 2026 Jul 7:S0735-1097(26)06758.
    

    >> Share

    
    

    
    J Cardiovasc Pharmacol

29. PUCHONGMART C, Rodriguez CC, Soliman D, Shotelersuk V, et al
    Pharmacologic Management of Type 2 Myocardial Infarction: An Underdefined Frontier.
    J Cardiovasc Pharmacol. 2026 Jul 6. doi: 10.1097/FJC.0000000000001855.
    

    >> Share

    
    
30. ZHENG W, Zhou Y, Ye B, Hu S, et al
    SGLT2 Inhibitors Attenuate Neutrophil-Mediated Endothelial Injury in Coronary Artery Disease With Type 2 Diabetes Mellitus Through a GREM1-Associated Smad Signaling Axis.
    J Cardiovasc Pharmacol. 2026;88:25-35.
    

    >> Share

    
    

    
    JAMA

31. YUAN J, Jiang X, Lu ZK
    Lead Exposure and the Coronary Heart Disease Epidemic.
    JAMA. 2026 Jul 16. doi: 10.1001/jama.2026.9341.
    

    >> Share

    
    
32. LANPHEAR BP
    Lead Exposure and the Coronary Heart Disease Epidemic-Reply.
    JAMA. 2026 Jul 16. doi: 10.1001/jama.2026.9344.
    

    >> Share

    
    
33. EINSTEIN AJ, Paez D
    Radiation Dose in Coronary Artery Disease Diagnostic Imaging-Reply.
    JAMA. 2026 Jul 13. doi: 10.1001/jama.2026.8929.
    

    >> Share

    
    
34. LI S, Jiang R
    Radiation Dose in Coronary Artery Disease Diagnostic Imaging.
    JAMA. 2026 Jul 13. doi: 10.1001/jama.2026.8926.
    

    >> Share

    
    

    
    Lancet

35. ZHU Y, Gaudino M, Zhao Q
    Physiology-guided coronary artery bypass grafting in valve surgery - Authors' reply.
    Lancet. 2026;408:218.
    

    >> Share

    
    
36. MAGOULIOTIS DE, Sicouri S, Ramlawi B
    Physiology-guided coronary artery bypass grafting in valve surgery.
    Lancet. 2026;408:217-218.
    

    >> Share

    
    
37. LIP GYH, Kuzma L
    Combination antithrombotic therapy in atrial fibrillation after coronary interventions: shorter duration, more safety?
    Lancet. 2026 Jul 15:S0140-6736(26)00747-6. doi: 10.1016/S0140-6736(26)00747.
    

    >> Share

    
    
38. SOTOMI Y, Kozuma K, Higuchi Y, Nakazawa G, et al
    1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.
    Lancet. 2026 Jul 15:S0140-6736(26)00665-3. doi: 10.1016/S0140-6736(26)00665.
    

    >> Share

    
    

    
    Mol Cell Biochem

39. HAN S, Li W, Huang Y, Xu Y, et al
    RPS5 modulates inflammatory response and angiogenesis in coronary heart disease through NF-kappaB signaling activation.
    Mol Cell Biochem. 2026 Jul 13. doi: 10.1007/s11010-026-05636.
    

    >> Share

    
    

    
    N Engl J Med

40. PARK KW, Kang J
    Balancing the Scales - Extended DAPT in Coronary Artery Disease.
    N Engl J Med. 2026;395:304-305.
    

    >> Share

    
    
41. YAMANOUCHI M, Tominaga N, Yonaha T
    Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis.
    N Engl J Med. 2026;395:311.
    

    >> Share

    
    
42. ZHANG Z, He S
    Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis.
    N Engl J Med. 2026;395:311.
    

    >> Share

    
    
43. MARCHINI M, Trezzi M
    Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis.
    N Engl J Med. 2026;395:311-312.
    

    >> Share

    
    
44. LOK CE, Polkinghorne KR, Tomlinson G
    Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis. Reply.
    N Engl J Med. 2026;395:312.
    

    >> Share

    
    
45. TIAN J, Wang Z, Wang Y, Wang F, et al
    Extended Dual Antiplatelet Therapy for Multivessel Coronary Artery Disease.
    N Engl J Med. 2026;395:233-242.
    

    >> Share

    
    

    
    PLoS One

46. REVATHI CK, Santhi H
    A novel dynamic Optuna hybrid Harris Hawks Optimization approach for classification of CAD.
    PLoS One. 2026;21:e0353605.
    

    >> Share

    
    
47. ZHU X, Wu Q, Kang Z, Chen S, et al
    Blood urea nitrogen to albumin ratio and mortality in critically ill patients with cardiogenic shock.
    PLoS One. 2026;21:e0352659.
    

    >> Share

    
    
48. SVENDSEN CD, Nielsen R, Larsen TH, Kuiper KKJ, et al
    The oral and lower airway microbiota and coronary heart disease in COPD patients and controls.
    PLoS One. 2026;21:e0353738.
    

    >> Share

    
    
49. JARAB AS, Al-Qerem W, Mansour R, Jarab H, et al
    Factors associated with low-density lipoprotein control in outpatients with myocardial infarction: A hospital-based study.
    PLoS One. 2026;21:e0353521.
    

    >> Share

    
    
50. JANG MH, Park S, Ann SH, Kim YG, et al
    Degree of hypertension and subclinical coronary atherosclerosis in asymptomatic individuals without cardiovascular disease.
    PLoS One. 2026;21:e0353359.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share